baber/WOPTO huggingface dataset:
Patent NZ-596585-A (NZ)
Title: Isoxazolines as inhibitors of fatty acid amide hydrolase
Inventor: CHAN LAWRENCE K
IPC: A61K31/42
Filed: 2010-05-18
Abstract: IP No. 596585 The present disclosure provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof. Conditions treated include a painful condition, an inflammatory condition, an immune disorder, a disorder of the central nervous system, a metabolic disorder, a cardiac disorder, glaucoma, neuropathic pain, central pain, deafferentiation pain, chronic pain, post–operative pain, preoperative pain, nociceptive pain, acute pain, non–inflammatory pain, inflammatory pain, pain associated with cancer, wound pain, burn pain, pain associated with medical procedures, pain resulting from pruritus, painful bladder syndrome, pain associated with premenstrual dysphoric disorder, pain associated with premenstrual syndrome, pain associated with chronic fatigue syndrome, pain associated with pre-term labor, pain associated with withdrawal symptoms from drug addiction, joint pain, arthritic pain, lumbosacral pain, musculo–skeletal pain, headache, migraine, muscle ache, lower back pain, neck pain, toothache dental/maxillofacial pain, visceral pain, a gastrointestinal disorder, a skin condition, neurotoxicity and/or neurotrauma, stroke, multiple sclerosis, spinal cord injury, epilepsy, a mental disorder, a sleep condition, a movement disorder, nausea and/or emesis, amyotrophic lateral sclerosis, Alzheimer’s disease, drug addiction, a wasting condition, an obesity-related condition and complication thereof, hypertension, circulatory shock, myocardial reperfusion injury and atherosclerosis
Patent NZ-597208-A (NZ)
Title: Method for producing a building having a prefabricated wood framework, and resulting building
Inventor: LITAIZE PIERRE-EMMANUEL
IPC: E04C2/26
Filed: 2010-08-24
Abstract: The disclosure relates to a method for producing a structure from prefabricated panels (1) to be connected mounted on a free-standing supporting framework, each of the panels being made beforehand from a wood framework (2) into which an inner insulation (3) and inner (4) and outer (5) facings are capable of being built, said panels (1) being connected together by a linking means in a vertical direction and in a horizontal direction, wherein said method is characterized in that a subassembly (6) is made from a quadrangular wood frame (7), inside of which vertical posts (12) are arranged on which mechanical connectors (13) are placed, enabling the arrangement, support, and prepositioning of a metal reinforcement (14) on the connectors (13) that are in place. The thus-produced subassembly (6) is placed in a mold (not shown) so as to be overmolded from concrete constituting the inner facing (4).
Patent NZ-599447-A (NZ)
Title: Acoustic panel
Inventor: BORRONI MARK
IPC: B32B3/20
Filed: 2010-10-21
Abstract: A panel (1) is disclosed including a substantially air impermeable membrane layer (3) and a layer (5) having apertures (6). Each membrane portion which overlies an aperture (6) defines a diaphragm (9) which is able to vibrate in response to sound waves and absorb at least part of the sound waves' energy. Some of the apertures (6) are arranged in clusters (11) where the greatest distance between adjacent apertures is less than the distance between any aperture in the cluster and any aperture outside of the cluster (11). Each region defined by the outer periphery of a cluster (11) forms a resonance absorber (13) which is able to vibrate in response to sound waves and absorb at least part of the sound waves' energy. At least one resonance absorber (13) provides sound absorption at a frequency which is different to the frequency of at least one of the individual diaphragms (9).
Patent NZ-602351-A (NZ)
Title: Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
Inventor: SAMPSON KIMBERLY S
IPC: A01H5/00
Filed: 2009-07-02
Abstract: 602351 Disclosed is a isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) the nucleotide sequence of SEQ ID NO:12, or a complement thereof; b) a nucleotide sequence having at least 96% sequence identity to the nucleotide sequence of SEQ ID NO:12, wherein said nucleotide sequence encodes a protein having insecticidal activity, or a complement thereof; c) a nucleotide sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14; and d) a nucleotide sequence that encodes a polypeptide comprising an amino acid sequence having at least 96% sequence identity to the amino acid sequence of SEQ ID NO:14, wherein said amino acid sequence has insecticidal activity. Further disclosed are polypeptides comprising the corresponding amino acid and plants and methods thereof. SEQ ID NO: 14MNMNKNNTKLSARALPSFIDYFNGIYGFATGIKDIMNMIFKTDTGGDLTLDEILKNQQLLNDISGKLDGVNGSLNDLIAQGNLNTELSKEILKIANEQNQVLNDVNNKLDAINTMLHVYLPKITSMLSDVMKPNYALSMQIEYLSRQLQEISDKLDIINVNVLINSTLTEITPAYQWIKYVNEKFEELTFATETTLKVKNDSASADILDELTELTELAKSVTKNDVDGFEFYLNTFHDVMVGNNLFGRSTLKTASELIAKENVKTSGSEVGNVYNFLVVLTALQAKAFLTLTTCRKLLGLADIDYTSIMNEHLNKEKEEFRVNILPILSNTFSNPNYAKVKGSDEDAKMIVEAKPGHALVGFEISNDSMTVLKVYEAKLKQNYQVDKDSLSEVIYGDMDKLLCPDQSEKIYYTNNIVFPNEYVITKIDFTKKMKTLRYEVTANSYDSSTGEIDLNKKKVESSKAEYRTLSANNDGVYMPLGVISETFLTPINGFGLQADENSRLITLTCKSYLRELLLATDLSNKETKLIVPPNSFISNIVENGSIEEGHLEPWKANNKNAYVDHTGGVNGTKALYVHEDGGVSQFMGDKLKPKTEYVIQYTVKGKPSIHLKDENTGYILYEDTNNDLEDFQTITKRFTTGTDLMRVYLILKSQSGHEAWGDNFTILEIKPAEALVSPELINPNSWITTQGASISGDKLFISLGTNGTFRQNLSLNSYSTYSISFTASGPFNVTVRNSREVLYERNNLMSSTSHISGEFKTESNNTGLYVELSRRSGGAGHISFENISIK
Patent NZ-607544-A (NZ)
Title: Granulated food product
Inventor: SHEN DONG
IPC: A23L23/10
Filed: 2011-09-08
Abstract: Disclosed is a method for preparing a granulated food product comprising plant material from one or more aromatic plants, a meaty base and an osmotic agent, wherein the total content of the plant material and the meaty base in the product is from 0.2 to 48 % by weight of dry matter, and wherein the product is in a granulated form with the average size of granules in the range 0.5 mm to 5.0 mm, comprising the steps: a) milling plant material from one or more aromatic plants together with a meaty base; b) mixing the milled material obtained from step a) with an osmotic agent at a temperature of -10 to 65 °C to form a viscous mixture having a moisture content of up to 30 % by weight; c) granulating the viscous mixture to obtain granules; and d) drying the granules to reduce the moisture content to 0.5 to 10 % by weight; wherein the osmotic agent is at least one of starch, maltodextrin, gum, wheat flour, rice flour, non-dairy creamer, or mixtures thereof.
Patent NZ-607753-A (NZ)
Title: Decision support system and method supplemented by strength-of-preference and scaling information
Inventor: PAUL HANSEN
IPC: G06Q10/10
Filed: 2013-03-01
Abstract: A decision support method for two or more pre-defined criteria and two or more profiles is disclosed. Each criterion comprises two or more pre-defined and ordinally ranked categories and each profile comprises a set of two or more of the criteria. Each criterion in the set is associated with one of the categories for that criterion, and where ordinal pairwise rankings of undominated profile pairs have already been received from a decision-maker. Each undominated profile pair comprises two profiles with one profile having a higher ranked category on at least one criterion and a lower ranked category on at least one other criterion than the other profile, having thereby enabled the calculation of a point value for each of the categories on the criteria and a total score for each of the profiles. Each total score comprises the sum of the corresponding point values. The method comprises including ratio scale measurements of the decision-maker’s preferences with respect to the relative importance to the decision-maker of some or all of the categories on the criteria relative to others as well as, optionally, values obtained from the decision-maker to enable the point values for the categories on the criteria and/or the total scores for the profiles to be linearly scaled in order to identify their respective points of zero value. The method also comprises solving a system of equalities/inequalities that represents the ordinal pairwise rankings of undominated profile pairs already received from the decision-maker and the ratio scale measurements of the decision-maker’s preferences with respect to the relative importance to the decision-maker of some or all of the categories on the criteria relative to others as well as, if they are optionally included, the values obtained from the decision-maker to enable the point values for the categories on the criteria and/or the total scores for the profiles to be linearly scaled in order to identify their respective points of zero value to obtain at least one output.
Patent NZ-614305-A (NZ)
Title: Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Inventor: HEXAMER LAURA
IPC: C07D405/12
Filed: 2009-12-04
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BCL-2 or BCL-XL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic BCL-2 protein. Examples of compounds of formula (I) include: 4-(4-((4’-chloro-1,1’-biphenyl-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(2-phenylethyl)benzamide; 2-(benzylamino)-4-(4-((4’-chloro-1,1’-biphenyl-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)benzamide; 4-(4-((4’-chloro-1,1’-biphenyl-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(phenoxymethyl)benzamide; 4-{ 4-[2-(3-azabicyclo[3.2.2]non-3-yl)benzyl]piperazin-1-yl} -2-phenoxy-N-({ 4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]-3-[(trifluoromethyl)sulfonyl]phenyl} sulfonyl)benzamide; 4-{ 4-[2-(3-azabicyclo[3.2.2]non-3-yl)benzyl]piperazin-1-yl} -2-phenoxy-N-({ 4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)benzamide; 4-{ 4-[2-(3-azabicyclo[3.2.2]non-3-yl)benzyl]piperazin-1-yl} -N-({ 4-[(3-morpholin-4-ylpropyl)amino]-3-nitrophenyl} sulfonyl)-2-phenoxybenzamide; 4-(4-{ 2-[(4R,7S)-2,3,3a,4,7,7a-hexahydro-1H-4,7-methanoinden-5-yl]benzyl} piperazin-1-yl)-N-({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)-2-phenoxybenzamide.
Patent NZ-615595-A (NZ)
Title: Wetting composition
Inventor: ROBERTS RAYMOND JOHN
IPC: C11D10/02
Filed: 2012-04-02
Abstract: Disclosed is a method of wetting a low energy hydrophobic surface (such as having a static or advancing water contact angle of greater than about 90 degrees) with a relatively high surface energy aqueous liquid, the method comprising the step of: adding a wetting composition to the liquid; and contacting the low energy surface with the liquid comprising the wetting composition, wherein the wetting composition comprises: greater than or equal to about 50 wt% of a C5 to C12 alcohol (most preferably octanol); and a non-ionic, anionic, cationic or zwitterionic surfactant (preferably an alcohol alkoxylate).
Patent NZ-617883-A (NZ)
Title: Lighting apparatus with a boost
Inventor: ROOMS ROB ALLEN
IPC: F21Y105/00
Filed: 2011-09-20
Abstract: 617883 A lighting apparatus is disclosed for installation in an exterior canopy (954) where water may pool on the upper surface of the canopy. The apparatus is in the form of a luminaire comprising a light panel (910) including light sources for mounting to the canopy (954), a driver box (960) housing an electrical driver for the light sources and an elongate boost (990) between the light panel (910) and the driver box (960). The boost supports the driver box (960) and spaces it above the light panel to keep the driver box out of any standing water that may accumulate on the canopy (954). The boost (990) may comprise electrical conduit to accommodate electrical wiring between the driver and the light panel.
Patent NZ-618949-A (NZ)
Title: Printing fluid cartridge, printing apparatus, and use of printing fluid cartridge
Inventor: KANBE TOMOHIRO
IPC: B41J2/175
Filed: 2011-12-22
Abstract: A printing fluid cartridge (30) is configured to be mounted to a cartridge mounting portion including an optical sensor and at least one contact. The printing fluid cartridge includes at least one electrical interface (75, 76), 77 configured to be electrically connected to the at least one contact, and a light attenuating portion (33) configured to be inserted between a light emitter and a light receiver of the optical sensor and to be detected by the optical sensor.
Patent NZ-623057-A (NZ)
Title: Guiding and/or support arrangement and method therefor
Inventor: KENNY PHILIP RICHARD
IPC: E05D15/06
Filed: 2011-09-30
Abstract: Disclosed is a guiding rail and track support system for a horizontal sliding hanging door that reduces the installation time of a timber dressing frame for the track system and allows for an improved surface finish. The guiding arrangement for guiding movement of one or more selected from a door and at least one wheel arrangement in a door assembly fitted into a framed opening in a wall, the guiding arrangement comprises a substantially vertical wall including framing members defining the framed opening, and lined on opposed sides with wallboard sheets. An elongate body member defines a guide path on which the one selected from a door and at least one wheel arrangement is guidable, wherein the guiding arrangement is installed into the framed opening by attaching the elongate body member to an underside of a lintel of the framed opening, with no additional intervening top dressing frame element. The elongate body is wider than the width of the framing members and further defines a pair of vertical surfaces, spaced apart from each other such that they are positioned substantially in plane with an exterior surface of each of the respective wallboards. The vertical surfaces either face the same direction as the exterior surface of each other respective wallboard sheet, or face an opposite direction as the exterior surface of each the respective wallboard sheet. Connector formations connect the elongate body member to a vertical support member at or towards an end of the elongate body member. The elongate body member defines a track arrangement along the guide path on which a wheel arrangement is reciprocally movable.
Patent NZ-624569-A (NZ)
Title: Rapid establishment and/or termination of substantial steady-state drug delivery
Inventor: LUSKEY KENNETH L
IPC: C40B30/04
Filed: 2010-09-21
Abstract: The disclosure relates to the use of an exenatide for the manufacture of a medicament for treating obesity a human by a method comprising: providing continuous delivery of the exenatide from an osmotic delivery device comprising: (1) an impermeable reservoir comprising interior and exterior surfaces and first and second open ends; (2) a semi-permeable membrane in sealing relationship with the first open end of the reservoir; (3) an osmotic engine within the reservoir and adjacent the semi-permeable membrane; (4) a piston adjacent the osmotic engine, wherein the piston forms a movable seal with the interior surface of the reservoir and divides the reservoir into a first chamber and a second chamber, the first chamber comprising the osmotic engine and the second chamber comprising a suspension formulation; and (5) a diffusion moderator inserted in the second open end of the reservoir, the diffusion moderator adjacent the suspension formulation, the suspension formulation comprising a particle formulation and a vehicle formulation, the particle formulation comprising particles comprising exenatide in particles of less than 10 microns in diameter and the vehicle formulation comprising: (i) a solvent selected from the group consisting of benzyl benzoate, lauryl lactate, and lauryl alcohol, and (ii) a polymer that is polyvinylpyrrolidone, the vehicle formulation having a viscosity between about 10,000 poise and about 20,000 poise at 37 degrees Celsius; wherein substantial steady-state delivery of the exenatide at a therapeutic concentration is achieved within a time period of 5 days or less after implantation of the osmotic delivery device in the human and the substantial steady-state delivery of the exenatide from the osmotic delivery device is continuous over an administration period of at least 3 months at a mcg/day dose of the exenatide selected from the group consisting of about 10 mcg/day, about 20 mcg/day, about 30 mcg/day, about 40 mcg/day, about 60 mcg/day, and about 80 mcg/day.
Patent NZ-630222-A (NZ)
Title: 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
Inventor: ANDERSON ERIC
IPC: C07J63/00
Filed: 2013-04-24
Abstract: The present disclosure relates generally to the compound: N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicen-4a-yl)-2,2-difluoropropanamide, polymorphic forms thereof, methods for preparation and use thereof, pharmaceutical compositions thereof, and kits and articles of manufacture thereof.
Patent NZ-630835-A (NZ)
Title: Vortex-type grit chamber
Inventor: NOONAN FRANCIS M
IPC: E03F5/14
Filed: 2013-08-29
Abstract: A grit removal unit (10) including an influent channel (40) directing wastewater with grit into a round grit removal chamber (16) and an effluent channel (32) receives wastewater output from the chamber. An output guide member (70) is mounted to allow selective adjustment of output flow opening width “c” to the effluent channel. The output guide member has a horizontal bottom (74) extending from the chamber into the effluent channel (32) across the width of the output opening, and a guide wall (76) extending upwardly from the guide member bottom. The guide wall has a forward end spaced from the chamber annular vertical wall to define the output flow opening width therebetween. Adjusting the flow using the gates allows for maintaining a high enough flow rate into the chamber so that the grit does not build up in the influent channel. Optionally, divider wall extends upwardly between the sides of the influent channel (50), and gates (60, 62) at the upstream end of the divider wall are adjustable to selectively open channel portions on opposite sides of the divider wall to manage flow.
Patent NZ-700976-A (NZ)
Title: Floor-standing air-conditioning apparatus
Inventor: IKEDA TAKASHI
IPC: F24F13/30
Filed: 2012-04-06
Abstract: A floor-mounted air conditioner comprising: a lower suction port (2a) having a suction opening that causes air to flow to inside an air conditioner main body (10) from a front surface side lower section of the main body (10); a discharge port (3) having a discharge opening that causes the air inside the main body to be discharged above the main body; a heat exchanger (9) inside the main body that air-conditions; a cross-flow fan (7) inside the main body, that forms a flow that causes the air that was caused to flow into the main body to pass through the heat exchanger (9) and be guided into the discharge port (3); a drain pan (11) positioned lower than the heat exchanger (9) in the height direction of the main body, and which receives water from condensation; and a lower diffuser (3a) arranged in the lower section of the discharge port (3) inside the main body, and having a shape so as to not slope towards the outside. The cross-flow fan (7) is arranged at a position that is lower than the discharge port (3) in the height direction of the main body and further on the rear surface side in the depth direction than the center of the main body. The heat exchanger (9) is formed in a V shape in which the bottom ends of a front surface side heat exchanger (9b) and a rear surface side heat exchanger (9c) are in contact and the cross-flow fan (7) is arranged so as to be positioned between the front surface side heat exchanger (9b) and the rear surface side heat exchanger (9c).
Patent NZ-701700-A (NZ)
Title: Bicyclically substituted uracils and the use thereof
Inventor: TERSTEEGEN ADRIAN
IPC: C07D471/04
Filed: 2013-05-03
Abstract: The present application relates to novel bicyclically substituted uracil derivatives, characterized by formulae (I), to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of heart failure, pulmonary hypertension, chronic obstructive pulmonary disease, asthma, kidney failure, nephropathy, fibrotic disorders of the internal organs and dermatological fibroses, and to the use thereof for production of medicaments for treatment and/or prophylaxis of heart failure, pulmonary hypertension, chronic obstructive pulmonary disease, asthma, kidney failure, nephropathy, fibrotic disorders of the internal organs and dermatological fibroses.
Patent NZ-706683-A (NZ)
Title: Joint compound, wall assembly, and methods and products related thereto
Inventor: MIKLOSZ MARK
IPC: C08L75/04
Filed: 2013-09-25
Abstract: Disclosed are aspects of board finishing systems. For example, in various aspects, disclosed are joint compound compositions, wall assemblies, methods of treating walls, and products related to any of the foregoing, including reinforcement trim, e.g., for protecting corners where boards meet, fasteners, and tape. The joint compound preferably is a drying type composition with reduced shrinkage property, and includes binder and hollow spheres, resulting in an ultra lightweight formulation in some embodiments. The joint compound composition can be applied in a one-coat treatment in preferred embodiments. Other aspects of board finishing system accommodate such a one-coat treatment to thusly allow a user to manipulate the compound closer to the plane of board as compared with conventional formulations. Joint tape and reinforcement trim can include non-swelling synthetic paper facing material in some embodiments.
Patent NZ-715573-A (NZ)
Title: Composition for preventing or treating renal diseases, containing dpp-iv inhibitor
Inventor: CHA DAE RYONG
IPC: A61P13/12
Filed: 2014-06-17
Abstract: The present invention relates to a composition comprising a compound of Chemical Formula 1 for preventing or treating renal diseases. The composition of the present invention improves lipid metabolism, prevents histological damage including renal fibrosis, alleviates microalbuminuria, and maintains nephrons of renal glomeruli. Therefore, the composition is useful for treating renal diseases.
Patent NZ-720444-A (NZ)
Title: Prodrugs of pyridone amides useful as modulators of sodium channels
Inventor: HADIDA-RUAH SARA
IPC: A61P19/02
Filed: 2014-12-12
Abstract: The invention relates to prodrug inhibitors of Nav 1.8 channels which possess phosphonate substituted pyridone moieties. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including pain. The prodrugs of the invention possess advantageous solubility and physicochemical properties.